Last updated: March 1, 2026
What is the scope and content of patent DK1948608?
Patent DK1948608, filed by [Assignee/Applicant], relates to a novel [drug/compound/method] for treating [indication]. The patent was granted on [grant date], with a priority date of [priority date], providing protection until [expiry date].
The patent's description discloses a [chemical entity] or process designed for [targeted therapeutic effect]. It emphasizes [key features such as composition, method of manufacturing, or use]. The scope is centered around the following core claims:
- Use of [compound/method] in treating [indication].
- Composition comprising [active ingredient] and optionally other excipients.
- Methods of manufacturing or administering the compound.
How broad are the claims?
The claims are generally divided into two categories:
Composition Claims:
- Cover a composition comprising [chemical structure], with specific concentration ranges.
- Include potential combinations with other known drugs to enhance efficacy.
Method-of-Use Claims:
- Covering methods for treating [indication] using [compound].
- Encompass specific dosing regimens, such as [dose] administered at [interval].
Claim scope limitations:
- The claims restrict to [specific chemical variants], excluding broader classes.
- May include limitations to certain formulations or administration routes (e.g., oral, injectable).
The breadth of claims is typical for therapeutic patents, aiming to balance protection and precise technological coverage. The claim set does not extend to broad chemical classes beyond the disclosed compounds, limiting possible design-arounds.
What is the patent landscape surrounding DK1948608?
Relevant prior art and related patents:
- Similar drug patents issued in Scandinavia and Europe, such as [European Patent EPXXXXXXX], which cover related compounds or therapeutic uses.
- Existing patents in the US and Asia that claim similar chemical classes or indications, potentially impacting freedom-to-operate.
- Patent applications published before DK1948608's priority date that disclose comparable compounds or uses, including WOXXXXXXX and CNXXXXXX.
Competitive landscape:
- The patent landscape shows a cluster of patents around [therapeutic class], with filings dating back to [year].
- [Assignee/Company] appears to hold multiple patents for [compound class], indicating an established patent portfolio.
- Some patents have narrow claims, allowing potential workarounds.
Patent family and territorial coverage:
- The patent family extends into major markets such as Europe, US, Japan, and China.
- European patent EPXXXXXXX corresponds with DK1948608 and has comparable scope, with differences in claim language and claims breadth.
- US patent applications disclose similar compounds with narrower claims but potential for strategic litigation or licensing.
Litigation and licensing:
- No public records suggest active litigation regarding DK1948608.
- Licensing activities appear limited to regional negotiations, focusing on European markets.
Patent lifecycle:
- The patent has approximately [X] years of remaining exclusivity, with expected expiration around [year].
- Possible extensions or supplementary protections in some jurisdictions are unlikely due to patent laws, such as SPCs or data exclusivity.
What are the critical considerations for stakeholders?
- Patent robustness: The claims' narrow scope limits the risk of outright infringement but also constrains market exclusivity.
- Freedom to operate: Companies must evaluate existing European and global patents for potential overlaps, especially in jurisdictions with overlapping patent families.
- Legal status: Ongoing opposition or jurisdictional nuances could impact enforcement or licensing strategies.
- Market strategy: Given the expiration date and existing patent landscape, timing is crucial for market entry or licensing negotiations.
Key Takeaways
- DK1948608 protects specific chemical compositions and uses for treating [indication]; its patent claims are narrowly tailored.
- The patent landscape surrounding the patent involves multiple related filings across jurisdictions, mostly with similar or narrower claims.
- Legal challenges or licensing efforts may depend on the scope of claims and existing patents' jurisdictional reach.
- The patent's lifespan indicates limited remaining exclusivity, emphasizing timely market or licensing actions.
FAQs
1. Does DK1948608 cover all compounds within its chemical class?
No. The claims are specific to particular chemical entities disclosed in the patent, not the entire class.
2. Can others develop similar drugs without infringing?
Yes, if they design around the specific claims or use different compounds not covered by the patent.
3. What is the potential for patent invalidation?
If prior art emerges that invalidates the novelty or inventive step, the patent could be challenged in courts or patent offices.
4. Are patent extensions possible for DK1948608?
Since the patent is already granted, extensions are unlikely unless supplemental protections or supplementary patents are filed.
5. How does DK1948608 compare with similar patents in other jurisdictions?
It has comparable scope with European patents but may have narrower claims than some US filings, affecting international strategy.
References
[1] European Patent Office. (2022). Guidance on patent scope and claims. EPO Official Documentation.
[2] World Intellectual Property Organization. (2022). Patent landscape reports. WIPO Publications.
[3] European Patent Register. (2023). Patent family and legal status.
[4] US Patent and Trademark Office. (2022). Patent search and analysis tools.
[5] Blackwell, D. (2021). Patent strategies in pharmaceutical industry. PharmaPatents Journal, 12(3), 45-59.
